{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:40:50Z","timestamp":1785238850246,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T00:00:00Z","timestamp":1478649600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00345-016-1968-2","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T03:50:20Z","timestamp":1478663420000},"page":"1073-1080","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study"],"prefix":"10.1007","volume":"35","author":[{"given":"Mohammad","family":"Abufaraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilian","family":"Gust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"\u00d6zsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaly","family":"Margulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Bensalah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Haitel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,9]]},"reference":[{"key":"1968_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A (2016) Cancer statistics. CA Cancer J Clin 66:7\u201330","journal-title":"CA Cancer J Clin"},{"key":"1968_CR2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.eururo.2013.03.032","volume":"63","author":"M Roupr\u00eat","year":"2013","unstructured":"Roupr\u00eat M et al (2013) European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol 63:1059\u20131071","journal-title":"Eur Urol"},{"key":"1968_CR3","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","volume":"107","author":"JD Raman","year":"2011","unstructured":"Raman JD, Messer J, Sielatycki JA, Hollenbeak CS (2011) Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973\u20132005. BJU Int 107:1059\u20131064","journal-title":"BJU Int"},{"key":"1968_CR4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","volume":"62","author":"G Lughezzani","year":"2012","unstructured":"Lughezzani G et al (2012) Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol 62:100\u2013114","journal-title":"Eur Urol"},{"key":"1968_CR5","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.juro.2015.11.036","volume":"195","author":"T Seisen","year":"2016","unstructured":"Seisen T et al (2016) Oncologic outcomes of kidney sparing surgery versus radical nephroureterectomy for the elective treatment of clinically organ confined upper tract urothelial carcinoma of the distal ureter. J Urol 195:1354\u20131361","journal-title":"J Urol"},{"key":"1968_CR6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nrurol.2011.96","volume":"8","author":"TF Chromecki","year":"2011","unstructured":"Chromecki TF et al (2011) Prognostic factors for upper urinary tract urothelial carcinoma. Nat Rev Urol 8:440\u2013447","journal-title":"Nat Rev Urol"},{"key":"1968_CR7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.eururo.2011.09.017","volume":"61","author":"TF Chromecki","year":"2012","unstructured":"Chromecki TF et al (2012) The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol 61:245\u2013253","journal-title":"Eur Urol"},{"key":"1968_CR8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.juro.2010.04.016","volume":"184","author":"RT Bryan","year":"2010","unstructured":"Bryan RT, Tselepis C (2010) Cadherin switching and bladder cancer. J Urol 184:423\u2013431","journal-title":"J Urol"},{"key":"1968_CR9","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.1158\/1078-0432.CCR-03-0262","volume":"10","author":"K Yoshinaga","year":"2004","unstructured":"Yoshinaga K et al (2004) N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma. Clin Cancer Res 10:5702\u20135707","journal-title":"Clin Cancer Res"},{"key":"1968_CR10","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1158\/1078-0432.CCR-07-1263","volume":"13","author":"K Gravdal","year":"2007","unstructured":"Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA (2007) A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 13:7003\u20137011","journal-title":"Clin Cancer Res"},{"key":"1968_CR11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/(SICI)1097-0215(19970822)74:4<446::AID-IJC15>3.0.CO;2-7","volume":"74","author":"K Nakanishi","year":"1997","unstructured":"Nakanishi K, Kawai T, Torikata C, Aurues T, Ikeda T (1997) E-cadherin expression in upper-urinary-tract carcinoma. Int J Cancer 74:446\u2013449","journal-title":"Int J Cancer"},{"key":"1968_CR12","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.eururo.2005.07.005","volume":"48","author":"G Fromont","year":"2005","unstructured":"Fromont G et al (2005) Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma. Eur Urol 48:764\u2013770","journal-title":"Eur Urol"},{"issue":"1443","key":"1968_CR13","first-page":"e7","volume":"78","author":"M Muramaki","year":"2011","unstructured":"Muramaki M, Miyake H, Terakawa T, Kusuda Y, Fujisawa M (2011) Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomy. Urology 78(1443):e7\u2013e12","journal-title":"Urology"},{"key":"1968_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-016-1835-1","author":"RL Favaretto","year":"2016","unstructured":"Favaretto RL et al (2016) Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study. World J Urol. doi:\n                        10.1007\/s00345-016-1835-1","journal-title":"World J Urol"},{"key":"1968_CR15","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2008.17.2361","volume":"27","author":"E Kikuchi","year":"2009","unstructured":"Kikuchi E et al (2009) Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 27:612\u2013618","journal-title":"J Clin Oncol"},{"key":"1968_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.02.028","author":"PA Humphrey","year":"2016","unstructured":"Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014part B: prostate and bladder tumours. Eur Urol. doi:\n                        10.1016\/j.eururo.2016.02.028","journal-title":"Eur Urol"},{"key":"1968_CR17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1464-410X.2008.08003.x","volume":"103","author":"M Remzi","year":"2009","unstructured":"Remzi M et al (2009) Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int 103:307\u2013311","journal-title":"BJU Int"},{"key":"1968_CR18","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1464-410X.2010.09217.x","volume":"105","author":"SF Shariat","year":"2010","unstructured":"Shariat SF et al (2010) International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 105:1402\u20131412","journal-title":"BJU Int"},{"key":"1968_CR19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.eururo.2009.11.035","volume":"57","author":"R Zigeuner","year":"2010","unstructured":"Zigeuner R et al (2010) Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 57:575\u2013581","journal-title":"Eur Urol"},{"key":"1968_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-016-1835-1","author":"RL Favaretto","year":"2016","unstructured":"Favaretto RL et al (2016) Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study. World J Urol. doi:\n                        10.1007\/s00345-016-1835-1","journal-title":"World J Urol"},{"key":"1968_CR21","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.eururo.2011.12.055","volume":"61","author":"M Rink","year":"2012","unstructured":"Rink M et al (2012) Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 61:854\u2013855","journal-title":"Eur Urol"},{"key":"1968_CR22","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.eururo.2007.09.036","volume":"52","author":"K Bensalah","year":"2007","unstructured":"Bensalah K, Montorsi F, Shariat SF (2007) Challenges of cancer biomarker profiling. Eur Urol 52:1601\u20131609","journal-title":"Eur Urol"},{"key":"1968_CR23","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.eururo.2012.01.021","volume":"61","author":"EK Cha","year":"2012","unstructured":"Cha EK et al (2012) Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol 61:818\u2013825","journal-title":"Eur Urol"},{"key":"1968_CR24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.urolonc.2010.01.005","volume":"30","author":"M Muramaki","year":"2012","unstructured":"Muramaki M et al (2012) Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resection. Urol Oncol Semin Orig Investig 30:161\u2013166","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"1968_CR25","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1158\/1078-0432.CCR-05-2387","volume":"12","author":"I Lascombe","year":"2006","unstructured":"Lascombe I et al (2006) N-Cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin Cancer Res 12:2780\u20132787","journal-title":"Clin Cancer Res"},{"key":"1968_CR26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/hupa.2001.21140","volume":"32","author":"KM Rieger-Christ","year":"2001","unstructured":"Rieger-Christ KM et al (2001) Expression of classic cadherins type I in urothelial neoplastic progression. Hum Pathol 32:18\u201323","journal-title":"Hum Pathol"},{"key":"1968_CR27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3835(01)00759-5","volume":"176","author":"U Cavallaro","year":"2002","unstructured":"Cavallaro U, Schaffhauser B, Christofori G (2002) Cadherins and the tumour progression: is it all in a switch? Cancer Lett 176:123\u2013128","journal-title":"Cancer Lett"},{"key":"1968_CR28","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0090-4295(03)00236-X","volume":"61","author":"SF Shariat","year":"2003","unstructured":"Shariat SF, Kim J, Raptidis G, Ayala GE, Lerner SP (2003) Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder. Urology 61:1140\u20131145","journal-title":"Urology"},{"key":"1968_CR29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.juro.2009.08.115","volume":"183","author":"SF Shariat","year":"2010","unstructured":"Shariat SF et al (2010) Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer. J Urol 183:68\u201375","journal-title":"J Urol"},{"key":"1968_CR30","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420\u20131428","journal-title":"J Clin Invest"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-016-1968-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-016-1968-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-016-1968-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T03:09:48Z","timestamp":1498273788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-016-1968-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,9]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["1968"],"URL":"https:\/\/doi.org\/10.1007\/s00345-016-1968-2","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,9]]}}}